Cargando…
In a flurry of PINK, mitochondrial bioenergetics takes a leading role in Parkinson's disease
For many years research in Parkinson's disease (PD) has linked mitochondrial dysfunction with the characteristic loss of dopaminergic neurons of the substantia nigra, accumulation of cytoplasmic inclusions termed Lewy bodies, and motor dysfunction (Henchcliffe & Beal, 2008). The most compel...
Autor principal: | Murphy, Anne N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378120/ https://www.ncbi.nlm.nih.gov/pubmed/20049706 http://dx.doi.org/10.1002/emmm.200900020 |
Ejemplares similares
-
Déjà vu with a twist: transglutaminases in bioenergetics and transcriptional dysfunction in Huntington's disease
por: Kazemi-Esfarjani, Parsa, et al.
Publicado: (2010) -
Could successful (mitochondrial) networking help prevent Huntington's disease?
por: Oliveira, Jorge M A, et al.
Publicado: (2010) -
A new way APP mismetabolism can lead to Alzheimer's disease
por: Hardy, John, et al.
Publicado: (2011) -
Salvaging hope: Is increasing NAD(+) a key to treating mitochondrial myopathy?
por: Lightowlers, Robert N, et al.
Publicado: (2014) -
Back to the future: a new ‘old’ lead for tuberculosis
por: Wright, Gerard D
Publicado: (2012)